Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecord History now lists a new revision entry v3.3.2 and removes the previous v3.3.1.SummaryDifference0.1%

- Check25 days agoChange DetectedThe Record History now shows a new revision entry (v3.3.1) and the previous entry (v3.2.0) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoved the banner about government funding and NIH operating status from the Record History page. This does not affect study data, status, or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check46 days agoChange DetectedVersion 2 (2021-10-12) updated the recruitment status for the study NCT04407988 in the record history.SummaryDifference0.1%

- Check76 days agoChange DetectedVersion updated from v3.0.2 to v3.2.0; no substantive content changes detected.SummaryDifference0.3%

- Check77 days agoChange DetectedUpdate to a newer revision tag (from v3.0.2 to v3.1.0); no substantive changes to core content or user-facing data.SummaryDifference0.3%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.